Pedmark Injection, Solution
Product Images NDC 73077-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pedmark (NDC 73077-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fennec Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pedmark 01)

FDA Label Image

Principal Display Panel (100 mL Vial Box)

Principal Display Panel (100 mL Vial Box)
This is a description of a medicine called Pedmark, which is a sterile solution for intravenous use only. Each mL of the solution contains 125mg of sodium thiosulfate provided as sodium thiosulfate anhydrous 80mg, 0.25mg of boron acid, NF and water for injection, USP. The recommended dosage of the medicine is not available, and the dosage and administration should be done as per the prescribing information. It is to be used to reduce the risk of ototoxicity associated with cisplatin in patients who are one month or older. The product is distributed by Fennec Pharmaceuticals, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.